Susanne Paukner
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
In vitro test of the novel antibiotic lefamulin alone and in combination with doxycycline against Mycoplasma genitalium.
Journal: Antimicrobial agents and chemotherapy
Published: December 13, 2024
Structural studies of ribosome from an anaerobic Bacteroidetes human pathogen Porphyromonas gingivalis.
Journal: Nucleic acids research
Published: October 24, 2024
Broth microdilution protocol for determining antimicrobial susceptibility of Legionella pneumophila to clinically relevant antimicrobials.
Journal: Journal of microbiological methods
Published: August 02, 2024
In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice.
Journal: International journal of molecular sciences
Published: April 08, 2024
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms.
Journal: The Journal of antimicrobial chemotherapy
Published: July 20, 2023
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark.
Journal: The Journal of antimicrobial chemotherapy
Published: April 19, 2022
A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria.
Journal: Future microbiology
Published: March 14, 2022
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.
Journal: Antibiotics (Basel, Switzerland)
Published: October 01, 2021
Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis.
Journal: Antibiotics (Basel, Switzerland)
Published: September 30, 2021
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Journal: Journal of global antimicrobial resistance
Published: August 02, 2021
Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.
Journal: BMC pulmonary medicine
Published: December 01, 2020
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model.
Journal: PloS one
Published: August 10, 2020
Last Updated: 09/26/2026